Coronary microvascular dysfunction as a chronic inflammatory state: Is there a role for omega-3 fatty acid treatment?

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Nutritional Science

Background:

• Coronary microvascular dysfunction (CMD) is a key factor in various cardiovascular diseases, including ischemia with no obstructive coronary artery disease and heart failure with preserved ejection fraction.
• CMD may represent a systemic small vessel disease affecting the brain and kidneys, with chronic inflammation playing a significant role in its pathophysiology.
• Specialized pro-resolving mediators, derived from omega-3 fatty acids, actively resolve inflammation and have shown cardiovascular benefits.

Purpose of the Study:

• To investigate the potential of omega-3 fatty acid treatment in attenuating coronary microvascular dysfunction.
• To explore the role of specialized pro-resolving mediators in managing CMD.

Main Methods:

• This study focuses on the known effects of omega-3 fatty acids on inflammation and cardiovascular health.
• The research hypothesizes a potential benefit of omega-3s on CMD based on their anti-inflammatory properties.
• Further clinical trials are needed to directly assess omega-3s' impact on CMD.

Main Results:

• Omega-3 fatty acid treatment is known to modulate inflammation.
• Omega-3s are associated with improved cardiovascular outcomes and reduced plaque progression.
• The specific effect of omega-3 fatty acid treatment on coronary microvascular dysfunction remains undetermined.

Conclusions:

• Coronary microvascular dysfunction is linked to chronic inflammation.
• Omega-3 fatty acids and their derived mediators play a role in inflammation resolution.
• The efficacy of omega-3 fatty acid treatment in improving coronary microvascular function requires further investigation.